Public Employees Retirement System of Ohio Sells 3,042 Shares of Cencora, Inc. (NYSE:COR)

Public Employees Retirement System of Ohio cut its stake in shares of Cencora, Inc. (NYSE:COR - Free Report) by 3.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 96,767 shares of the company's stock after selling 3,042 shares during the period. Public Employees Retirement System of Ohio's holdings in Cencora were worth $21,780,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. New Millennium Group LLC acquired a new position in Cencora during the 2nd quarter worth about $26,000. MFA Wealth Advisors LLC acquired a new position in shares of Cencora in the second quarter worth approximately $30,000. Concord Wealth Partners bought a new stake in Cencora in the third quarter valued at approximately $30,000. SYSTM Wealth Solutions LLC acquired a new stake in Cencora during the 2nd quarter valued at approximately $36,000. Finally, Ashton Thomas Securities LLC bought a new position in Cencora during the 3rd quarter worth approximately $41,000. 97.52% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. UBS Group increased their price target on Cencora from $275.00 to $285.00 and gave the stock a "buy" rating in a report on Thursday, November 7th. Barclays upped their target price on shares of Cencora from $263.00 to $290.00 and gave the stock an "overweight" rating in a research note on Thursday, November 7th. Mizuho began coverage on shares of Cencora in a research report on Wednesday, December 4th. They set an "outperform" rating and a $280.00 target price on the stock. Bank of America reissued a "neutral" rating and issued a $245.00 price objective (down previously from $275.00) on shares of Cencora in a research report on Wednesday, September 18th. Finally, JPMorgan Chase & Co. lifted their target price on Cencora from $280.00 to $287.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 21st. Two investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $276.80.

Cencora Price Performance

Shares of COR stock traded down $5.14 on Wednesday, reaching $231.87. The company's stock had a trading volume of 1,714,899 shares, compared to its average volume of 1,391,167. The company has a market capitalization of $44.82 billion, a P/E ratio of 30.87, a PEG ratio of 1.62 and a beta of 0.45. Cencora, Inc. has a 12-month low of $195.83 and a 12-month high of $253.27. The stock's 50 day simple moving average is $237.88 and its 200-day simple moving average is $233.83. The company has a quick ratio of 0.53, a current ratio of 0.88 and a debt-to-equity ratio of 4.84.

Cencora Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a dividend of $0.55 per share. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.95%. The ex-dividend date of this dividend was Friday, November 15th. This is an increase from Cencora's previous quarterly dividend of $0.51. Cencora's dividend payout ratio (DPR) is 29.29%.

Insider Transactions at Cencora

In other news, Chairman Steven H. Collis sold 21,509 shares of the company's stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $242.16, for a total value of $5,208,619.44. Following the completion of the transaction, the chairman now directly owns 306,752 shares in the company, valued at approximately $74,283,064.32. This represents a 6.55 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Over the last 90 days, insiders sold 93,018 shares of company stock valued at $22,478,942. 15.80% of the stock is owned by corporate insiders.

Cencora Company Profile

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.